Search
  • SBIJI Innovation

LogicBio Therapeutics Announces Submission of Investigational New Drug Application (IND) for LB-001

January 10, 2020

LogicBio Therapeutics Announces Submission of Investigational New Drug Application (IND) for LB-001 for Methylmalonic Acidemia (MMA) and Highlights Key Corporate Milestones

Read more

20 views

A Member firm of SBI Group, Japan

© 2020 SBI JI Innovation Advisory Ltd. All rights reserved